Complement receptor type 1 (CR1)/the C3b/C4b receptor (1), and CR3, the iC3b receptor (2), of myelomonocytic cells have been shown to be involved in the phagocytosis of particles bearing the C3b and iC3b cleavage fragments of C3. Two states of activity exist for these receptors, a resting state, in which CR1 and CR3 only bind ligand-coated particles, and an activated state, in which these receptors also mediate the phagocytosis of such particles. The activated state was first described (3) when complement receptors on murine peritoneal macrophages were shown to acquire phagocytic capability after treatment of cells with soluble products of activated T cells. Subsequently, PMA was bound to impart phagocytic function on CR1 and CR3 of human monocytes and neutrophils (4, 5), and also to induce ligand-independent internalization of CRI by these cells (6). Finally, the capacity of three proteins of the extracellular matrix, fibronectin (FN) (5, 7, 8), serum amyloid P (5), and laminin (9), and activate CR1 and CR3 suggests that this alteration of receptor function may occur physiologically when cells migrate to the extravascular space.
COMPLEMENT RECEPTOR PHOSPHORYLAT1ON
CNBr-activated Sepharose 4 B and protein A-Sepharose (Pharmacia Fine Chemicals, Piscataway, N J) were purchased. All other chemicals were purchased from Sigma Chemical Co., St. Louis, MO.
Antibodies. YZ-1 isan lgG1 monoclonalanti-CR1 (6) . 3GS.10monoclonalanti-human neutrophil FcR (13) was a gift of Dr. Jay Unkeless, The Rockefeller University, New York. HB-5 is an IgG2a monoclonal anti-CR2 (11) . W6/32, an IgG2a mAb, recognizes a common determinant on the HLA-A, -B, and -C heavy cbain (14) . MMA, a monoclonal IgM that recognizes a determinant on myelomonocytic cells (15) , was a gift of Dr. Thomas Tedder, Dana-Farber Cancer Institute, Boston, MA. B1, an IgG2a mAb that recognizes a determinant on human B lymphocytes (16) (Coulter Immunology, Hialeab, FL); OKM 1, an IgG2b mAb directed at human CR3 (2); OKT3, an mAb specific for human T cells (17) (Ortho Pharmaceuticals, Raritan, NJ); UPC10, an IgG2a myeloma with specificity for levan; MOPC 141, an IgG2b myeloma with no known specificity (Bionetics, Kensington, MD); and FITC-labeled goat F(ab')~ anti-mouse F(ab')~ (Jackson ImmunoResearcb Labs, Inc., Avondale, PA), were purchased. Antibodies were coupled to CNBr-activated Sepharose 4 B at a ratio of 1-2 mg protein per milliliter gel.
Flow cytometric analysis for membrane protein expression was performed using the Ortho Systems 50 H Cytofluorograf (Ortho Diagnostics, Westwood, MA) as described (6) .
Cell Preparations. Human erythrocytes were obtained from citrated blood after repeated washings and removal of buffy-coat cells. Neutrophils were purified from peripheral blood by dextran sedimentation and centrifugation through Ficoll-Paque (18) . Tonsils were obtained after routine tonsillectomy. Single-cell suspensions were prepared, and contaminating neutrophils and erythrocytes were removed by centrifugation through Ficoll-Paque. Adherent cells were depleted during a 1-h incubation at 37 °C of tonsil cells in plastic tissue culture plates (Costar, Cambridge, MA). Contaminating macrophages in the final lymphocyte preparation were counted by fluorescent flow cytography of MMAstained cells. Peripheral blood monocytes were purified (19) by elutriation using a J2-21 centrifuge (Beckman Instruments, Inc., Palo Alto, CA) equipped with a JE-6 elutriator rotor with one standard separation chamber. The purity of the monocytes was >85%, as assessed by MMA-staining. Eosinophils were purified to >98% purity on discontinuous gradients of hypertonic Metrizamide (20) . Cells of the human B lymphoblastoid line SB (21) were maintained in RPMI-1640 medium with 10% FBS.
Preparation of ~2PO4-labeled Cells. Cells were labeled with 3~p by a modification of a previously described procedure (22) . 107 cells/ml were initially depleted of intracellular phosphate by incubation with buffer lacking PO4 -3 (30 mM Hepes, pH 7.4, 110 mM NaCI, I 0 mM KCI, I 0 mM glucose, 1 mM CaCI2, 1 mM MgCI2, 2 mM L-glutamine, and 2 mg/ml BSA) for 60 rain at 37°C. Cells were resuspended to 5 X 107 cells/ml in buffer with "~'~P-labeled phosphoric acid (orthophosphoric acid, 50 mCi/ml in HCl-free water; New England Nuclear, Boston, MA) at 1 mCi/ml for 90 rain at 37°C. After labeling, cells were washed twice, resuspended in buffer, and immediately subjected to appropriate stimulation.
Immunoprecipitation and SDS-PAGE Analysis of Membrane Proteins. Phosphorylation
reactions were stopped and ceils were lysed by the addition of an equal volume of ice-cold 2x RIPA buffer (2% NP-40, 0.2% SDS, 0.15 M NaCl, 10 mM NaH~PO4, 10 mM Na.~HPO4, 0.68 M sucrose, 5 mM EDTA, 10 mM NaF, 5 mM sodium pyrophosphate, 1 mM sodium vanadate, 1 mM ATP, 10 mM DFP, 2 ~M leupeptin, 2 #M peptstatin, 100 /~g/ml DNase, 5% FCS, pH 7.2). This lysis buffer was designed to inhibit maximally phosphatase (23) and protease activities, as well as to disrupt intact cytoskeletal components (24) with which membrane proteins may be associated. Cell lysates were incubated on ice for 30 rain, and insoluble material was removed by centrifugation at 25,000 g for 20 min at 4°C. Lysates were precleared by incubation overnight with protein A-Sepharose at 4°C. After centrifugation to remove the beads, lysates were sequentially incubated for 90 min with the control antibody UPC10-Sepharose, followed by YZ-1, HB5, 3G8.10, or W6/32-Sepharose to immunoprecipitate CR1, CR2, FcR, or HLA class I heavy chain, respectively. For the immunoprecipitation of CR3, cell lysates were first incubated for 90 rain with the nonspecific control antibody, MOPC 141 IgG, followed by addition of protein A-Sepharose. After centrifugation to remove the beads, CR3 was immunoprecipitated by sequential incubation with OKMI IgG and protein A-Sepharose. The beads were washed five times with ice-cold RIPA buffer, and adsorbed proteins were eluted by incubation with 1% SDS for 5 rain at 100 °C. The eluates were lyophilized, redissolved in sample buffer without SDS, and subjected to SDS-PAGE on 5-15% polyacrylamide slab gels (25) . Autoradiographs were prepared by exposing dried gels to XAR X-Omat film (Kodak) with Cronex Xtra Life Intensifying Screens (Dupont) at -70°C for 1-5 d.
Results
Analysis of Phosphorylation of CR1 by Neutrophils, Monocytes, and Eosinophils. To determine if stimulation of neutrophils with PMA was associated with the phosphorylation of CR1, s~PO4-1abeled neutrophils were prepared from two individuals who differed in their structural CR 1 ailotypes, having the FF and FS phenotypes, respectively (26, 27) . Replicate samples of 5 x 10 v cells from each donor were incubated for 2 min at 37°C in 3 ml of buffer alone or containing 100 ng/ml PMA. The reaction was ended and CR1 was immunoprecipitated from the cell lysates and analyzed by SDS-PAGE and autoradiography (Fig. 1) . CR 1 was not constitutively phosphorylated in neutrophils, despite incubation for >90 min in the presence of 32p04. The addition of PMA led to the phosphorylation of both the F and S allotypes of the receptor.
The kinetics of PMA-induced phosphorylation of CR1 by neutrophils was examined by incubating replicate samples of 5 x 107 cells in 3 ml of buffer alone or with 100 ng/ml PMA at 37°C for 3, 6, 12, and 24 min, respectively. After lysis of the cells, CR1 and the heavy chain of HLA class I, an endogenously phosphorylated protein (28) , were immunoprecipitated and analyzed by SDS-PAGE and autoradiography (Fig. 2) . Phosphorylation of CR1 was not detectable in the absence of PMA, peaked 3 rain after addition of this agent, and declined during the subsequent 21 rain of incubation. In contrast, the phosphorylation of the HLA heavy chain was constitutive and only slightly increased after addition of PMA to the neutrophils. As occurred with CRI, detection of HLA phosphorylation was greatly reduced by 24 min. The decline in labeling of these proteins observed in neutrophils may have been secondary to depletion of the intracellular pool of [S2P]ATP, because subsequent experiments with B lymphocytes (Fig. 6 ) demonstrated persistent labeling of HLA and complement receptors.
The chemotactic peptide FMLP has been shown to cause translocation of intracellular CRI to the plasma membrane (29) and to activate CR1 for phagocytosis in concert with FN (8) . Replicate samples of 10 s S2po4-1abeled neutrophils in 6 ml buffer were incubated at 37°C with 10 -7 M FMLP for 20, 60, and 180 s, respectively. Additional samples of 5 x 107 labeled neutrophils in 3 ml buffer were incubated with 100 ng]ml PMA for the same intervals. The cells were lysed and CR1 was immunoprecipitated and analyzed. FMLP rapidly induced the phosphory]ation of CRI, which peaked within 20 s of addition of the peptide, was less at 60 s, and was almost absent at 180 s (Fig. 3) . In contrast, PMAinduced phosphorylation of CR1 was undetectable at 20 s, and was greatest at 180 s (Fig. 3 ). Since twice as many cells were employed for the FMLP stimulation, it is apparent that the maximal extent of CR1 phosphorylation induced by FMLP was substantially less than that caused by PMA. FIGURE l. PMA-induced phosphorylation of the S and F allotypes of" neutrophil CR1. Autoradiograph of SDS-PAGE analysis of CR1 from 32po4-1abeled neutrophils that had been treated with buffer alone (0 rain) or with 100 ng/ml PMA for 2 rain. Neutrophils were from individuals who were heterozygous (left) and homozygous (righ 0 for the CR1 allotypes.
Numbers on the right refer to the positions of standard proteins having the indicated M, X 10 -3" Two other neutrophil membrane proteins involved in phagocytic reactions, CR3 and the FcR, were also analyzed for phospborylation induced by PMA. Two replicate samples of 5 X 107 ~2po4-1abeled neutrophils in 3 ml buffer were incubated at 37°C for 3 rain in the presence or absence of 100 ng/ml PMA. The detergent lysates were prepared and sequentially immunoprecipitated with UPC10, YZ-1, 3G8.10, and OKM1. The immunoprecipitated proteins were analyzed by SDS-PAGE and autoradiography. In the absence of PMA, the phosphorylation of CR3 and FcR was not apparent, indicating that these membrane proteins differed from HLA class I antigen (28) in not being constitutively phosphorylated (Fig. 4) . In addition, these receptors differed from CR1 by exhibiting no PMA-induced phosphorylation (Fig. 4) .
The phosphorylation of CR1 by two other phagocytic cell types, monocytes and eosinophils, was examined. Replicate samples of 2.5 x 10 7 monocytes and FIGURE 2. Kinetics of PMA-induced phosphorylation by neutrophils of HLA class I heavy chain and CR 1. Membrane proteins were immunoprecipitated from 32PO4-1abeled neutrophils that had been treated with buffer or with 100 ng/ml PMA for timed intervals, and were analyzed by SDS-PAGE and autoradiography. Numbers on the right refer to the positions of standard proteins having the indicated Mr X 10 -s. eosinophils that had been prelabeled with 32P0 4 were incubated for 3 min at 3 7°C in 3 ml buffer alone or containing 100 ng/ml PMA. CR1 and CR3 were immunoprecipitated from detergent lysates o f the cells and assessed by SDS-PAGE and autoradiography. As was found for neutrophils, CR1 of monocytes was not constitutively phosphorylated but became modified in this manner upon stimulation o f the cells with PMA for 3 min (Fig. 5 left) . CR3 of monocytes was not phosphorylated, constitutively or after stimulation (Fig. 5 left) . Analysis of CR1 from eosinophils that had been treated for three min with PMA indicated COMPLEMENT RECEPTOR PHOSPHORYLATtON that the receptor on this third phagocytic cell type was also capable of being phosphorylated (Fig. 5 right) .
Analysis of Phosphorylation of CR1 and CR2 by B Lymphocytes. To determine if phosphorylation of CR ! was restricted to phagocytic cell types, tonsilar cells were examined for this reaction. In addition, because these cells also express CR2, the C3d/EBV receptor, this membrane protein was also assessed for phosphorylation. Although the B lymphocyte would be the major source of CR1 in this cell population, two other potential sources are present, T lymphocytes and macrophages. Only 10% of T lymphocytes express CR1 (30) , and the number of receptors present on these cells is <10% that present on B lymphocytes. Therefore, T lymphocytes were not removed from the preparation of cells assessed for phosphorylation of CR1. Conversely, macrophages express large amounts of CR 1 and three methods were used to effect their removal from the tonsilar cells. Each method, adherence to plastic culture dishes, adherence to Sephadex G-10, or elutriation, reduced the proportion of MMA ÷ macrophages by 50% indicating that it was not possible to totally remove this cell type. Therefore, replicate samples of 5 x 107 '~2PO4-1abeled tonsilar cells, which had been depleted of plastic-adherent cells and which were comprised of 45% B1 + lymphocytes, 48% T3 + lymphocytes, and 5% MMA + macrophages, were incubated at 37°C in 3 ml of buffer alone or in buffer containing 100 ng/ml PMA for 2 or 20 rain. CR1, 107 32PO4-1abeled monocytes and eosinophils that had been treated with buffer or with 100 ng/ml PMA for 3 rain, and were analyzed by SDS-PAGE and autoradiography. Numbers on the right refer to the positions of standard proteins having the indicated Mr X 10 -3.
CR2
, and H L A class I were immunoprecipitated f r o m each cell lysate, and analyzed by SDS-PAGE and autoradiography. Phosphorylation of CR1 was undetectable at to and, although detectable at 2 and 20 min following stimulation with PMA (Fig. 6) , it was markedly less than that observed with the phagocytic cell types (Figs. 1-5 ). In contrast, CR2, which also was not constitutively phosphorylated, became intensely labeled following B lymphocyte activation by PMA (Fig. 6) . Thus, CR2, rather than CR1, is the p r e d o m i n a n t phosphorylated c o m p l e m e n t receptor of the B lymphocyte. Further, CR2, H L A , and CR1 all showed persistent labeling at 20 min, suggesting the intracellular ~2p-labeled ATP pool had not been depleted in this cell population, as had probably occurred in neutrophils (Fig. 2) . To characterize further the potential of B lymphocyte CR1 for phosphorylation after activation of protein kinase C, the human B lymphoblastoid line, SB, was examined. Since monocytes and neutropbils express ~50,000 CR 1 molecules per cell, and SB cells express only 5,000 (P. S. Changelian and D. T. Fearon, unpublished observations), it was necessary to use 10 times as many SB cells for a comparable analysis. Replicate samples of 2 × 108 ~2PO4-1abeled SB cells were incubated in 15 ml buffer alone or with 100 ng/ml PMA for 2 min at 37°C. Replicate samples of 2 × 107 ~2po4-1abeled monocytes in 1.5 ml buffer were identically treated. After iysis, CR1 and CR2 from SB cells and CR1 from monocytes were immunoprecipitated, and the eluted proteins analyzed by SDS-PAGE and autoradiography (Fig. 7) . Although phosphorylation of monocyte CR1 was readily detectable following stimulation with PMA for 2 min, an equivalent number of CR 1 molecules from SB cells exhibited no phosphorylation. In contrast, CR2 from SB cells became intensely phosphorylated after PMA FIGURE 7 . Analysis of PMA-induced phosphorylation of CR1 and CR2 in SB cells and monocytes. Membrane proteins were immunoprecipitated from 2 x 108 ~PO4-1abeled SB cells or 2 × 107 ~2PO4-1abeled monocytes that had been treated with buffer or with 100 ng/ml PMA for 2 rain, and were analyzed by SDS-PAGE and autoradiography. Numbers on the right refer to the positions of standard proteins having the indicated Mr x 10 -3.
stimulation, analogous to the findings in normal B lymphocytes (Fig. 6) . Buffertreated SB cells displayed low levels of CR2 phosphorylation, which is in contrast to the lack of constitutive phosphorylation of CR2 found in tonsilar B lymphocytes (Fig. 6) . However, the immunoprecipitates f r o m SB cells contained ~15-fold greater n u m b e r s of CR2 molecules than were present in the immunoprecipitates from tonsilar cells, perhaps accounting for detection of constitutive phosphorylation.
T o d e t e r m i n e whether PMA can induce phosphorylation of CR1 on another nonphagocytic cell type, replicate samples of 5 x 109 32PO4-1abeled erythrocytes were incubated at 37°C in 3 ml buffer alone or containing 100 ng/ml PMA for 2 or 20 min. 100-fold m o r e erythrocytes were used because this cell type expresses only 500 receptors/cell, whereas myelomonocytic cells and B lympho- cytes express 50,000 receptors/cell. Although PMA increased the phosphorylation of several erythrocyte proteins, phosphorylation of CR1 was not detected (Fig. 8) .
Discussion
The transition of CR1 on myelomonocytic cells from the resting to the activated state, in which it can mediate phagocytosis of C3b-coated particles, can be induced by a variety of agents. These agents, such as T cell-derived lymphokines (3), phorbol esters (4, 5), and extracellular matrix proteins (5, 7-9), have pleiotropic effects on the cells they activate. A biochemical mechanism correlating this cellular activation to the activation of CR1 has not been found. In this stud), we have shown PMA-inducibility of CR 1 phosphorylation that is specific for cells of the myelomonocyte lineage, and phosphorylation of CR2 rather than of CR 1 by B lymphocytes.
Phosphorylation is an important mechanism for regulation of cellular protein function, examples being the enzymes involved in glycogen metabolism (3 l) and the contractile proteins of muscle cells (32) . A general role for phosphorylation in the activation of human neutrophils has been suggested by studies (22, 33) demonstrating enhanced phosphorylation of four to six proteins in cells stimulated with PMA or FMLP. A protein of Mr 44,000, normally phosphorylated after PMA induction, is absent in cells from patients with chronic granulomatous disease (34) . These human phosphoproteins, however, have not been identified, in contrast to studies of rabbit neutrophils activated with FMLP, in which enhanced phosphorylation of vimentin (35) and myosin light chain (36) was shown. Thus, the phosphorylation of a specific protein in human neutrophils in association with a change in that protein's function has not been demonstrated.
The evidence suggesting that phosphorylation of CR1 by stimulated myelomonocytic cells is the structural basis for the activated state of the receptor is correlative. As has been found for phagocytosis by CR 1, phosphorylation of the receptor did not occur constitutively in any cell type. Incubation of neutrophils, monocytes, and eosinophils in the presence of 32po4 for up to 90 min was not associated with phosphorylation of CR1, despite intense labeling of HLA class I heavy chain (Figs. 1-5) . The absence of phosphorylation of CR 1 by unstimulated cells also is in contrast to the constitutive pbosphorylation of other membrane proteins present on these cell types, such as the transferrin receptor (37) and the leukocyte common antigen (T200) (38) . Therefore, the induction of phosphorylation of CR 1 on myelomonocytic cells by PMA correlates with the acquisition of phagocytic function by CR 1. The induction of CR 1 phosphorylation by FMLP supports this conclusion because this chemotactic peptide also confers phagocytic activity on CR1 in the presence of FN (8) . The more rapid kinetics of FMLPinduced phosphorylation is caused by the peptide inducing a rapid turnover of inositol phospholipids (39) , with transient activation of protein kinase C by diacylglycerol. Phosphorylation of CR1 by PMA-treated monocytes and neutrophils was selective, with CR3 and FcR not being subject to this form of covalent modification. We do not have an explanation for the absence of phosphorylation of CR3, which has also been reported to be functionally activated by PMA (4) .
The restriction of phosphorylation of CR1 to myelomonocytic cells is perhaps the most interesting finding in support of a causal relationship between phosphorylation of CR 1 and phagocytosis. All three phagocytic cell types, neutrophils, monocytes, and eosinophils, were capable of phosphorylating CR1 (Figs. 1-5) , whereas two nonphagocytic cell types, erythrocytes and normal and transformed B lymphocytes (Figs. 6-8) , were not. This tissue-specificity of CR1 phosphorylation may be secondary to structural differences between receptors of different cell types. For example, minor differences have been detected in the glycosylation of CR1 on different cell types that do not, however, correlate with the occurrence of phospborylation (40) . Differences in the cytoplasmic domain of CR1 would be a more likely mechanism accounting for the tissue-specificity of CR1 phosphorylation. These differences might occur through alternative splicing of the CR 1 primary transcript, by analogy to the generation of membrane and secreted forms of immunoglobulin (41) , or by the presence of multiple CR1 genes. The latter possibility is unlikely because CR1 ailotypes present on myelomonocytic cells are the same as those found on lymphocytes and erytbrocytes (26, 42) . Analysis of potential cell type-dependent variations in the cytoplasmic domain of the receptor will now be possible based on the recent cloning of a partial cDNA for CR1 (43) . Two additional mechanisms that might account for the tissue-specific phosphorylation of CR1 are: different cytoplasmic environments regulating access of the protein kinase to CR l, and tissue-specificity of the kinase responsible for phosphorylation of CR1. Although PMA is known to activate protein kinase C, it cannot be concluded that protein kinase C phosphorylates CR1. For example, other studies (44) have shown that phosphorylation of ribosomal protein $6 in 3T3-L1 cells treated with PMA was mediated by $6 kinase rather than by protein kinase C. Whatever mecbanism is involved in CR 1 phosphorylation, its restriction to cell types capable of engaging in phagocytosis suggests that this covalent modification of the receptor is related to its activation.
Although PMA-stimulated B lymphocytes did not mediate the phosphorylation of CR1, CR2 was phospborylated by these cells. This contrast may indicate that CR2, by analogy to CR1 of myelomonocytic cells, has resting and activated states, the latter caused by covalent modification by phosphorylation. The recent reports that simulation of B lymphocytes with antibody to CR2 requires the presence of T lymphocytes or soluble factors elaborated by T cells (45) (46) (47) would be consistent with a two-step process of B cell activation by this complement receptor. As CR2 also serves as the B cell receptor for EBV (12) , it will be of interest to determine the effects of this herpesvirus on phosphorylation of CR2. Summary CR1 of neutrophils and monocytes may exist in a resting state, in which it only binds ligand-coated particles, or an activated state, in which it mediates phagocytosis. Because the activated state of CR 1 can be induced by the stimulation of protein kinase C with PMA, CR1 was assessed for phosphorylation. Purified human neutrophils, monocytes, eosinophils, tonsilar lymphocytes, SB cells, and erythrocytes were labeled with ~2po4 and incubated with buffer or I00 ng/ml PMA. Membrane proteins were immunoprecipitated and analyzed by SDS-PAGE and autoradiography. CR 1, unlike HLA class I heavy chain, was not constitutively phosphorylated by any cell type. PMA induced phosphorylation of CR1 in three phagocytic cell types, but did not induce the phosphorylation of CR3 or FcR. FMLP also induced the phosphorylation of CR1 in neutrophils. In contrast, PMA did not induce phosphorylation of CR1 in tonsilar B lymphocytes, SB cells, or erythrocytes, indicating restriction of this reaction to phagocytic cell types. This may be due to differences in the structure or presentation of the cytoplasmic domain of CR1 in phagocytic vs. nonphagocytic cells. Phosphorylation of CR2, however, did occur in PMA-treated B lymphocytes and SB cells, suggesting that this receptor, rather than CR1, may be involved in regulation of B lymphocyte function.
